Louis Dreyfus, a major player in the food ingredients and agriculture marketplace, contends the new purchase will help grow its global reach in the plant-based space. In the press release, the company pointed to BASF’s portfolio of oils, fats, glycerin and lecithin as key assets in the deal.“We see strong potentiaferrous fumarate 140mg/5ml oral solution sugar freel to accelerate LDC’s evolution from reliable raw material provider to trusted solutions advisor as well, partnering our global customers to develop attractive applications for bakery & confectionary, non-dairy, instant foods, personal care and healthcare,” said James Zhou, chief commercial officer at Louis Dreyfus.For BASF, the sale gives the company room to focus on growing other areas of its business. The company said its plant-based unit is no longer a “strategic focus area” and has “limited synergies” within its operations.“We remain committed to ferrous bisglycinate uses in teluguleveraging our core producferrous bisglycinate 36.5 mgt platforms and expanding our business in key areas such as vitamins, carotenoids and feed enzymes,” Michael Heinz, a member of ferrous fumarate powderBASF’s board of executive directors, said in a statement.The plant-based meat segment has struggled in recent years, with companies like Beyond Meat and Impossible Foods cutting jobs, tweaking their marketing strategies and prioritizing innovation. BASF’s divestiture could help it improve cash flow by abandoning a struggling category.In recent years, Louis ferrous sulfate or ferrous gluconateDreyfus has increased its presence in the protein ingredients space. Last summer, the Netherlands-based company formed a dedicated business unit focused on pulses such as beans and lentils. Earlier in 2024, the processor announced plans to build a pea protein facility in Canada.
Louis Dreyfus buys BASF’s food and health ingredients business
